BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21157436)

  • 1. Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.
    Kantor B; Bayer M; Ma H; Samulski J; Li C; McCown T; Kafri T
    Mol Ther; 2011 Mar; 19(3):547-56. PubMed ID: 21157436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors.
    Shaw AM; Joseph GL; Jasti AC; Sastry-Dent L; Witting S; Cornetta K
    Gene Ther; 2017 Jan; 24(1):12-20. PubMed ID: 27682478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.
    Bayer M; Kantor B; Cockrell A; Ma H; Zeithaml B; Li X; McCown T; Kafri T
    Mol Ther; 2008 Dec; 16(12):1968-76. PubMed ID: 18797449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.
    Takayama K; Torashima T
    J Neurovirol; 2009 Sep; 15(5-6):371-9. PubMed ID: 19739019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-inactivating lentiviral vectors with U3 and U5 modifications.
    Iwakuma T; Cui Y; Chang LJ
    Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo.
    Philippe S; Sarkis C; Barkats M; Mammeri H; Ladroue C; Petit C; Mallet J; Serguera C
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17684-9. PubMed ID: 17095605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient gene expression by nonintegrating lentiviral vectors.
    Nightingale SJ; Hollis RP; Pepper KA; Petersen D; Yu XJ; Yang C; Bahner I; Kohn DB
    Mol Ther; 2006 Jun; 13(6):1121-32. PubMed ID: 16556511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleeping beauty transposition from nonintegrating lentivirus.
    Vink CA; Gaspar HB; Gabriel R; Schmidt M; McIvor RS; Thrasher AJ; Qasim W
    Mol Ther; 2009 Jul; 17(7):1197-204. PubMed ID: 19417741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrase defective, nonintegrating lentiviral vectors.
    Michelini Z; Negri D; Cara A
    Methods Mol Biol; 2010; 614():101-10. PubMed ID: 20225038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector integration profiles differ in rodent postmitotic tissues.
    Bartholomae CC; Arens A; Balaggan KS; Yáñez-Muñoz RJ; Montini E; Howe SJ; Paruzynski A; Korn B; Appelt JU; Macneil A; Cesana D; Abel U; Glimm H; Naldini L; Ali RR; Thrasher AJ; von Kalle C; Schmidt M
    Mol Ther; 2011 Apr; 19(4):703-10. PubMed ID: 21364536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
    Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
    Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid lentivirus-transposon vectors with a random integration profile in human cells.
    Staunstrup NH; Moldt B; Mátés L; Villesen P; Jakobsen M; Ivics Z; Izsvák Z; Mikkelsen JG
    Mol Ther; 2009 Jul; 17(7):1205-14. PubMed ID: 19240688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nondividing cells: a safer bet for integrating vectors?
    Brady T; Bushman FD
    Mol Ther; 2011 Apr; 19(4):640-1. PubMed ID: 21455211
    [No Abstract]   [Full Text] [Related]  

  • 14. Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation.
    Scholz SJ; Fronza R; Bartholomä CC; Cesana D; Montini E; von Kalle C; Gil-Farina I; Schmidt M
    Hum Gene Ther; 2017 Oct; 28(10):875-885. PubMed ID: 28825370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective gene therapy with nonintegrating lentiviral vectors.
    Yáñez-Muñoz RJ; Balaggan KS; MacNeil A; Howe SJ; Schmidt M; Smith AJ; Buch P; MacLaren RE; Anderson PN; Barker SE; Duran Y; Bartholomae C; von Kalle C; Heckenlively JR; Kinnon C; Ali RR; Thrasher AJ
    Nat Med; 2006 Mar; 12(3):348-53. PubMed ID: 16491086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases.
    Pelascini LP; Maggio I; Liu J; Holkers M; Cathomen T; Gonçalves MA
    Hum Gene Ther Methods; 2013 Dec; 24(6):399-411. PubMed ID: 24059449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of nonintegrating lentiviral vectors for gene therapy.
    Philpott NJ; Thrasher AJ
    Hum Gene Ther; 2007 Jun; 18(6):483-9. PubMed ID: 17523890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-integrating lentiviral vectors.
    Sarkis C; Philippe S; Mallet J; Serguera C
    Curr Gene Ther; 2008 Dec; 8(6):430-7. PubMed ID: 19075626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel integrase-defective lentiviral episomal vectors for gene transfer.
    Vargas J; Gusella GL; Najfeld V; Klotman ME; Cara A
    Hum Gene Ther; 2004 Apr; 15(4):361-72. PubMed ID: 15053861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase.
    Moldt B; Staunstrup NH; Jakobsen M; Yáñez-Muñoz RJ; Mikkelsen JG
    BMC Biotechnol; 2008 Aug; 8():60. PubMed ID: 18691430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.